Literature DB >> 22170753

In vivo MRI and histopathological assessment of tumor microenvironment in luminal-like and basal-like breast cancer xenografts.

Else M Huuse1, Siver A Moestue, Evita M Lindholm, Tone F Bathen, Hawa Nalwoga, Kristi Krüger, Anna Bofin, Gunhild M Maelandsmo, Lars A Akslen, Olav Engebraaten, Ingrid S Gribbestad.   

Abstract

PURPOSE: To explore tumor pathophysiology with special attention to the microenvironment in two molecular subtypes of human breast cancer using in vivo magnetic resonance imaging (MRI) and histopathology. The impact of tumor growth, size, and the influence of estradiol were also investigated.
MATERIALS AND METHODS: Two orthotopic and directly transplanted human breast cancer models representing luminal-like and basal-like molecular subtypes were characterized by dynamic contrast-enhanced MRI and diffusion-weighted MRI. Ex vivo measurements of vascularization, hypoxia, mitoses, and the level of VEGF activations were associated with the calculated in vivo MRI parameters of the tumors.
RESULTS: The vascular permeability and perfusion (K(trans) ) was significantly higher in basal-like compared to luminal-like tumors. These findings were confirmed by a 4-fold higher proliferating microvessel density (pMVD) in basal-like tumors, reflecting the difference in aggressiveness between the subtypes. No effect of tumor growth was observed during 6 days of growth in any of the models; however, large tumors had lower K(trans) , higher extracellular extravascular volume fraction (v(e) ), and more hypoxia than medium-sized tumors. Estradiol withdrawal induced increased K(trans) , v(e) , and tumor water diffusion (ADC) in luminal-like tumors, corresponding to increased VEGFR2 activation, which is likely to cause increased tumor vessel permeability.
CONCLUSION: These novel data confirm the potential of functional MRI methods to map histopathologically proven changes in breast tumor vasculature and microenvironment in vivo.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22170753     DOI: 10.1002/jmri.23507

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  12 in total

1.  Dynamic (18) F-FDG PET for Assessment of Tumor Physiology in Two Breast Carcinoma Xenografts.

Authors:  Alexandr Kristian; Line B Nilsen; Kathrine Røe; Mona-Elisabeth Revheim; Olav Engebråten; Gunhild M Mælandsmo; Ruth Holm; Eirik Malinen; Therese Seierstad
Journal:  Nucl Med Mol Imaging       Date:  2013-06-21

2.  Proteomic characterization of breast cancer xenografts identifies early and late bevacizumab-induced responses and predicts effective drug combinations.

Authors:  Evita M Lindholm; Marit Krohn; Sergio Iadevaia; Alexandr Kristian; Gordon B Mills; Gunhild M Mælandsmo; Olav Engebraaten
Journal:  Clin Cancer Res       Date:  2013-11-05       Impact factor: 12.531

3.  Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastoma.

Authors:  Cecilie Brekke Rygh; Jian Wang; Marte Thuen; Andrea Gras Navarro; Else Marie Huuse; Frits Thorsen; Aurelie Poli; Jacques Zimmer; Olav Haraldseth; Stein Atle Lie; Per Øyvind Enger; Martha Chekenya
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

4.  Differential in vivo tumorigenicity of distinct subpopulations from a luminal-like breast cancer xenograft.

Authors:  Nirma Skrbo; Geir-Olav Hjortland; Alexandr Kristian; Ruth Holm; Silje Nord; Lina Prasmickaite; Olav Engebraaten; Gunhild M Mælandsmo; Therese Sørlie; Kristin Andersen
Journal:  PLoS One       Date:  2014-11-24       Impact factor: 3.240

Review 5.  Current and Emerging Magnetic Resonance-Based Techniques for Breast Cancer.

Authors:  Apekshya Chhetri; Xin Li; Joseph V Rispoli
Journal:  Front Med (Lausanne)       Date:  2020-05-12

6.  Metabolic biomarkers for response to PI3K inhibition in basal-like breast cancer.

Authors:  Siver A Moestue; Cornelia G Dam; Saurabh S Gorad; Alexandr Kristian; Anna Bofin; Gunhild M Mælandsmo; Olav Engebråten; Ingrid S Gribbestad; Geir Bjørkøy
Journal:  Breast Cancer Res       Date:  2013-02-28       Impact factor: 6.466

7.  Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis.

Authors:  J Chuck Harrell; Adam D Pfefferle; Nicole Zalles; Aleix Prat; Cheng Fan; Andrey Khramtsov; Olufunmilayo I Olopade; Melissa A Troester; Andrew C Dudley; Charles M Perou
Journal:  Clin Exp Metastasis       Date:  2013-08-22       Impact factor: 5.150

8.  Intratumoral heterogeneity of breast cancer xenograft models: texture analysis of diffusion-weighted MR imaging.

Authors:  Bo La Yun; Nariya Cho; Mulan Li; Min Hye Jang; So Yeon Park; Ho Chul Kang; Bohyoung Kim; In Chan Song; Woo Kyung Moon
Journal:  Korean J Radiol       Date:  2014-09-12       Impact factor: 3.500

9.  Anti-vascular effects of the cytosolic phospholipase A2 inhibitor AVX235 in a patient-derived basal-like breast cancer model.

Authors:  Eugene Kim; Hanna Maja Tunset; Jana Cebulla; Riyas Vettukattil; Heidi Helgesen; Astrid Jullumstrø Feuerherm; Olav Engebråten; Gunhild Mari Mælandsmo; Berit Johansen; Siver Andreas Moestue
Journal:  BMC Cancer       Date:  2016-03-07       Impact factor: 4.430

10.  Identification of Potential MR-Derived Biomarkers for Tumor Tissue Response to 177Lu-Octreotate Therapy in an Animal Model of Small Intestine Neuroendocrine Tumor.

Authors:  Mikael Montelius; Johan Spetz; Oscar Jalnefjord; Evelin Berger; Ola Nilsson; Maria Ljungberg; Eva Forssell-Aronsson
Journal:  Transl Oncol       Date:  2018-01-11       Impact factor: 4.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.